Comparative study of Revogene GBS LB assay and GeneXpert GBS LB assay for the detection of group B Streptococcus in prenatal screening samples

Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC therefore recommends GBS screening for all pregnant women at 35 –37 weeks of gestati...

Source: BMC Infectious Diseases - January 14, 2020 Category: Infectious Diseases Authors: Tsokyi Choera, Brittney Jung-Hynes and Derrick J. Chen Tags: Research article Source Type: research